Tetsuya Homma Selected Research

Tetsuya Homma Research Topics

Disease

23	Asthma (Bronchial Asthma) 04/2024 - 01/2007
14	Inflammation (Inflammations) 04/2024 - 06/2007
8	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 12/2015
6	COVID-19 08/2023 - 01/2020
5	Rhinosinusitis 11/2022 - 12/2015
5	Virus Diseases (Viral Diseases) 01/2022 - 01/2007
4	Infections 01/2023 - 01/2016
3	Nasal Polyps (Nasal Polyp) 11/2022 - 12/2015
3	Lung Injury 05/2021 - 09/2011
3	Pneumonia (Pneumonitis) 05/2021 - 08/2019
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2020 - 08/2019
3	Airway Remodeling 01/2020 - 05/2009
3	Hypersensitivity (Allergy) 01/2017 - 09/2011
2	Polyps 11/2022 - 01/2017
2	Respiratory Insufficiency (Respiratory Failure) 11/2021 - 01/2020
2	Allergic Bronchopulmonary Aspergillosis 11/2021 - 06/2016
2	Eosinophilia 11/2020 - 01/2017
2	Hypercapnia 10/2020 - 01/2018
2	Neoplasm Metastasis (Metastasis) 04/2020 - 09/2019
2	Dyspnea (Shortness of Breath) 01/2020 - 01/2020
2	Bacterial Infections (Bacterial Infection) 01/2019 - 12/2017
1	Hypoxia (Hypoxemia) 12/2022
1	Disease Progression 12/2022
1	Emphysema 08/2022
1	Atrial Fibrillation 11/2021
1	Respiratory Hypersensitivity 11/2021
1	Organizing Pneumonia 09/2021
1	Cough 05/2021
1	Abscess 02/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2021
1	False Aneurysm (Pseudoaneurysm) 02/2021
1	Hemoptysis 02/2021
1	Rupture 02/2021
1	Lung Neoplasms (Lung Cancer) 02/2021
1	Sarcopenia 01/2021
1	Vasculitis (Vasculitides) 11/2020
1	Microscopic Polyangiitis 11/2020
1	Hypoventilation 10/2020
1	Heart Diseases (Heart Disease) 10/2020
1	Fatigue 08/2020
1	Frailty 08/2020
1	Metaplasia 06/2020

Drug/Important Bio-Agent (IBA)

8	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2024 - 01/2009
5	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2008
5	CytokinesIBA 01/2021 - 01/2009
4	Interleukin-13IBA 04/2024 - 12/2015
4	AllergensIBA 01/2022 - 01/2012
4	Immunoglobulin E (IgE)IBA 05/2021 - 09/2015
4	Interleukin-17 (Interleukin 17)IBA 09/2010 - 01/2007
3	InterleukinsIBA 11/2021 - 01/2011
3	ChemokinesIBA 01/2021 - 01/2007
3	ErbB Receptors (EGF Receptor)IBA 08/2019 - 04/2015
2	Dexamethasone (Maxidex)FDA LinkGeneric 08/2023 - 09/2021
2	Oxygen (Dioxygen)IBA 08/2023 - 01/2008
2	AntibodiesIBA 01/2023 - 01/2020
2	Cystatin CIBA 12/2022 - 01/2021
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2022 - 01/2007
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2007
2	Interferon LambdaIBA 01/2022 - 01/2021
2	Carbon DioxideIBA 10/2020 - 01/2018
2	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 08/2020 - 01/2020
2	LigandsIBA 07/2020 - 01/2017
2	anti-IgE antibodiesIBA 06/2016 - 02/2012
2	EnzymesIBA 01/2016 - 09/2015
2	Fluticasone (Cutivate)FDA LinkGeneric 01/2013 - 02/2012
2	Interleukin-33IBA 01/2013 - 01/2011
1	Tiotropium Bromide (Spiriva)FDA Link 04/2024
1	Interleukin-5 (Interleukin 5)IBA 04/2024
1	Muscarinic M3 ReceptorIBA 04/2024
1	OvalbuminIBA 04/2024
1	SteroidsIBA 01/2024
1	AntigensIBA 01/2023
1	C-Reactive ProteinIBA 12/2022
1	RetinoidsIBA 11/2022
1	fibrin fragment D (D-dimer)IBA 11/2022
1	FibrinIBA 11/2022
1	Plasminogen Activators (Plasminogen Activator)IBA 11/2022
1	Leukocyte Elastase (Neutrophil Elastase)IBA 08/2022
1	mepolizumabIBA 11/2021
1	Yi-Gan SanIBA 05/2021
1	daisaikotoIBA 05/2021
1	Plant ExtractsIBA 05/2021
1	CreatinineIBA 01/2021
1	AlbuminsIBA 01/2021
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2020
1	Epidermal Growth Factor (EGF)IBA 11/2020
1	Sirtuin 1IBA 08/2020
1	ninjin'yoeitoIBA 08/2020
1	IpilimumabIBA 07/2020
1	NivolumabIBA 07/2020
1	brigatinibIBA 04/2020
1	alectinibIBA 04/2020

Therapy/Procedure

12	Therapeutics 01/2024 - 02/2012
3	Artificial Respiration (Mechanical Ventilation) 08/2023 - 01/2016
2	Radiotherapy 02/2021 - 09/2019
1	Catheter Ablation 11/2021
1	Extracorporeal Membrane Oxygenation 09/2021
1	Activities of Daily Living (ADL) 10/2020
1	Kampo Medicine (Kampo) 08/2020
1	Immunotherapy 07/2020